Caldwell & Orkin’s Paychex PAYX Stock Holding History

Caldwell & Orkin’s Portfolio PAYX Stock Details PAYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-59,095	Closed	-$3.48M	–	81
2017 Q1	$3.48M	Buy	+59,095	New	+$3.59M	1.94%	11
2015 Q3	–	Sell	-44,000	Closed	-$2.06M	–	88
2015 Q2	$2.06M	Buy	44,000 +8,500	+24%	+$416K	1.2%	34
2015 Q1	$1.76M	Sell	35,500 -11,700	-25%	-$568K	0.98%	44
2014 Q4	$2.18M	Buy	+47,200	New	+$2.18M	1.22%	32

Other funds holding PAYX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Caldwell & Orkin's PAYX Position: Q2 2017 in Review

Caldwell & Orkin sold out of Paychex (PAYX) in Q2 2017, closing a stake of 59,095 shares — an estimated $3.48M sold.

Caldwell & Orkin first reported a position in PAYX in Q4 2014 and held it in 4 quarters. The position peaked at $3.48M in Q1 2017. 876 funds tracked by Wall St. Rank hold PAYX as of Q2 2017.

Caldwell & Orkin reported no remaining Paychex position as of Q2 2017 after selling out during the quarter.
Caldwell & Orkin sold 59,095 Paychex shares in Q2 2017, an estimated $3.48M.
Caldwell & Orkin first reported a position in Paychex in Q4 2014 and held it in 4 quarters.
Caldwell & Orkin's Paychex position peaked at $3.48M in Q1 2017.
876 funds tracked by Wall St. Rank held Paychex as of Q2 2017.

Based on Caldwell & Orkin's 13F filing for Q2 2017, filed 10 Aug 2017.